MedTrace Logo

Immunization Delivery in Obstetrics and Gynecology Settings

NCT01565135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97087

Last updated 2019-06-24

No results posted yet for this study

Summary

The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), and influenza vaccines, than the usual care provided to patients in ob/gyn practices.

Conditions

  • Immunization Status Among Obstetrics and Gynecology Patients

Interventions

BEHAVIORAL

Multimodal Vaccine Program

Efforts will be made to collaborate with private ob/gyn offices to develop a multimodal intervention to improve patients'immunization rates. As part of the overall intervention, intervention practices will agree to 1) purchase, stock, and administer influenza, HPV, and Tdap vaccines, if not already doing so and 2) track patients' vaccination status. In addition, intervention strategies adopted by intervention settings to improve immunization rates may include: * Patient education regarding the importance of vaccination, including encouragement of vaccination for family members * Practice-based reminder/recall * Seek to decrease missed opportunities for immunization by using either or both of the following: provider prompts and/or provider education and feedback

Sponsors & Collaborators

Principal Investigators

  • Sean O'Leary, MD, MPH · University of Colorado Denver, Children's Hospital Colorado

  • Amanda Dempsey, MD, PhD, MPH · University of Colorado, Children's Hospital Colorado

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01565135 on ClinicalTrials.gov